| Market Cap | ₹69,508Cr |
| ROE | 17.69% |
| P/E Ratio(TTM) | 28.84 |
| EPS(TTM) | 201.58 |
| P/B Ratio | 5.21 |
| Dividend Yield | 0.77% |
| Industry P/E | 32.40 |
| Book Value | 1116.21 |
| Debt to Equity | 0.18 |
| Face Value | 2 |
| Managing Director | Dr. Vikas Gupta |
| Founded | 1973 |
| NSE Symbol | ALKEM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.41 | ||
| Cipla | NA (0.00%) | 23.91 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.98 | ||
| Lupin | NA (0.00%) | 23.17 |